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T-cell receptor binding to MHC-bound peptides plays a key role in discrimination 
between self and non-self. Only a subset, typically a pentamer, of amino acids in a 
MHC-bound peptide form the motif exposed to the T-cell receptor. We categorize and 
compare the T-cell exposed amino acid motif repertoire of the total proteomes of two 
groups of bacteria, comprising pathogens and gastrointestinal microbiome organisms, 
with the human proteome and immunoglobulins. Given the maximum 205, or 3.2 million 
of such motifs that bind T-cell receptors, there is considerable overlap in motif usage. 
We show that the human proteome, exclusive of immunoglobulins, only comprises three 
quarters of the possible motifs, of which 65.3% are also present in both composite bac-
terial proteomes. Very few motifs are unique to the human proteome. Immunoglobulin 
variable regions carry a broad diversity of T-cell exposed motifs (TCEMs) that provides a 
stratified random sample of the motifs found in pathogens, microbiome, and the human 
proteome. Individual bacterial genera and species vary in the content of immunoglobulin 
and human proteome matched motifs that they carry. Mycobacteria and Burkholderia 
spp carry a particularly high content of such matched motifs. Some bacteria retain a 
unique motif signature and motif sharing pattern with the human proteome. The impli-
cation is that distinguishing self from non-self does not depend on individual TCEMs, 
but on a complex and dynamic overlay of signals wherein the same TCEM may play 
different roles in different organisms, and the frequency with which a particular TCEM 
appears influences its effect. The patterns observed provide clues to bacterial immune 
evasion and to strategies for intervention, including vaccine design. The breadth and 
distinct frequency patterns of the immunoglobulin-derived peptides suggest a role of 
immunoglobulins in maintaining a broadly responsive T-cell repertoire.
Keywords: T-cell repertoire, human proteome, microbiome, T-cell epitope, immunogenetics, central tolerance, 
Mycobacterium, Burkholderia
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inTrODUcTiOn
A central theme of immunology is the ability of the adaptive 
immune system to differentiate self from non-self. Much of the 
ability to mount a specific immune response is dependent on 
T-cell recognition of cognate peptide epitopes in the context of the 
MHC molecules determined by the host’s genetics. In this analy-
sis, we examine the limitations of the T-cell epitope repertoire in 
distinguishing self from non-self by categorizing and comparing 
the TCEM repertoire of two groups of bacterial proteomes with 
that of the human proteome and immunoglobulins.
We have previously reported on the characteristics of T-cell 
exposed amino acid motifs of peptides bound in MHC molecules 
in mediating T-cell recognition and polyspecificity (1). T-cell 
exposed motifs (TCEMs) are the combinations of amino acids, 
typically pentamers, whose side chains are exposed to T-cell 
receptors when an epitope peptide is bound within a MHC 
groove. A TCEM is exposed to the T-cell within the context of 
the surrounding MHC histotope. Conversely, some of the amino 
acid side chains of the MHC-bound peptide are hidden to the 
T-cell receptor and are directed into the MHC groove, where they 
determine the binding affinity of the peptide to the MHC and thus 
the kinetic stability, or dwell time, during which T-cell receptor 
engagement occurs. Based on the structural analysis of Rudolph 
et al., three pentameric contact patterns of TCEMs are recognized 
(2). For MHC I, these comprise amino acids 4,5,6,7,8 of a core 
9-mer, and for MHC II two patterns, which we call TCEM IIa 
and IIb, comprising the amino acids 2,3,5,7,8 and -1,3,5,7,8 of 
the central 9-mer core of a 15-mer (1, 2). These contact patterns 
are summarized in Figure 1. A pentamer contact pattern sets the 
maximum number of TCEM configurations that T-cells recog-
nize at 205, or 3.2 million, for each of the contact patterns. This 
determines the need for polyspecificity, and enables a finite T-cell 
population to respond to all potential epitopes (3, 4).
T-cell exposed motifs provide a framework to understand 
large protein sets from the perspective of T-cell recognition. 
We showed previously that in IgV the amino acids mak-
ing up the TCEM assort independently of the amino acids 
FigUre 1 | T-cell-exposed motif patterns. In each contact pattern the 
black markers indicate the T-cell exposed amino acids, while the white 
markers indicate the groove exposed amino acids. The numbers identify 
amino acids positions in each motif using the MHC groove pocket numbering 
scheme.
making  up  the  intercalated groove exposed motif (GEM) (1). 
The T-cell engagement is with the histotope and the exposed 
amino acids of the MHC-bound peptide, but not with the 
groove exposed amino acids. The T-cell–TCEM interaction is 
not influenced by the GEM except in so far as the latter deter-
mines the binding affinity and thus how long the peptide remains 
associated with the MHC to enable repeated T-cell interactions 
to occur. Therefore, we approached this analysis by looking first 
at the TCEM motifs alone.
For any protein, there is a gradation in frequency of T-cell 
encounter with different TCEMs present in that protein. 
Common TCEMs will cause repeated clonal stimulation leading 
to a buildup of a larger population of cognate T-cells, whereas rare 
TCEM will have fewer encounters and generate a smaller cognate 
population (4). The motif usage patterns previously observed in 
the IgV prompted us to examine the patterns of occurrence of 
TCEMs in other large protein sets relevant to the function of the 
immune system: the human proteome exclusive of the immuno-
globulins, and two exemplary groups of bacteria. The first group 
of bacteria comprises 67 species in 35 genera from the gastro-
intestinal microbiome. The second group comprises up to five 
proteomes each of 28 species in 12 genera of pathogenic bacteria. 
We characterized the patterns of potential TCEM present within 
each proteome dataset, and compared them to each other, and to 
the repertoire of motifs in IgV regions.
The interdependency of the B-cell immunoglobulin variable 
regions (IgV) and T-cell suppressor repertoires has long been 
recognized (5). Peptides derived from IgV are processed, bound 
in MHC, and presented to T-cells as are other peptides of other 
origins (6–8). B-cells present their own endogenous IgV-derived 
peptides in MHC (9), a process that is thought to play a key role 
in determining T-cell diversity (10, 11). We reported that within 
IgV regions there is a high rate of repetitive appearance of TCEM 
of both germline-origin and those resulting from somatic hyper-
mutation (1). In a sample of “normal” IgV, from which sequences 
originating from immunopathologies had been eliminated, 
estimated to be approximately equivalent to 1% of the population 
of B-cell clonotypes in any one individual (12), we showed that 
approximately 50% of the TCEMs recur in at least 1 in every 1024 
B-cell clonal products. We proposed that the peptides derived 
from IgV, and presented on MHC by B-cells and by other antigen 
presenting cells (APCs), provide the constantly cycling peptide 
diversity needed to maintain an active T-cell repertoire required 
to mount an appropriate immune response to a vast diversity of 
antigens, both self and non-self, of pathogen or environmental 
origin.
We find that the human proteome uses only about three 
quarters of the total possible pentamers in each TCEM contact 
pattern and thus the immune system has evolved mechanisms 
to recognize and respond appropriately to the other quarter of 
the motifs. The bacterial species share motifs with the human 
proteome but in addition contain nearly all of the TCEMs not 
found in the human proteome, a characteristic that highlights the 
importance in immune recognition of the sampling of the micro-
biome by the gut associated lymphatic tissue. The IgV-derived 
TCEMs provide a broad representation of the other proteomes 
and also generate TCEMs not found in any of the three proteome 
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datasets. Within the bacterial pathogen dataset we can differenti-
ate protein-specific, genus-specific, and some species specific 
patterns in TCEM usage. Overall, the relationship points to the 
role of TCEM frequency in pathogen immune evasion, tolerance 
of commensals, and the potential for generation of autoimmune 
responses following bacterial infection or disturbance of the 
microbiome.
MaTerials anD MeThODs
Protein sets
Four groups of protein sequences were assembled:
a. Human proteome (human proteome): this group comprises 
88,146 proteins, including multiple isoforms of proteins, with 
an average length of 384 amino acids. As a whole, the set thus 
provides about a fourfold redundancy of the approximately 
20,000 proteins in any individual human proteome. This 
set of proteins was assembled from the UniProt repository1 
(13), and based on the UniProt annotations it was manually 
curated to remove the proteins containing immunoglobulin 
variable regions. The final curated set comprised 3.3 ×  107 
total TCEM in each of the three contact patterns.
b. Gastrointestinal microbiome bacteria (microbiome): the pro-
teomes were assembled from the NIH Human Microbiome 
Project Reference Genomes database2 and included 67 species 
in 35 genera (listed in Table S1 in Supplementary Material). 
This set comprised a total of 378,061 proteins with an average 
length of 290 amino acids. This is not a set of fully annotated 
proteomes and may include some partial proteomes. The 
final set comprised 1.09 × 108 total TCEM in each of the three 
contact patterns and is thus of a comparable total size to the 
bacterial pathogen set in (c).
c. Exemplary bacterial pathogens (pathogens) comprising 
28 species each represented by up to five proteomes (132 
in all) selected at random from the complete proteomes of 
each genus available at PATRIC3 (14). The genera included 
were: Bordetella, Brucella, Burkholderia, Chlamydia, 
Clostridium, Coxiella, Francisella, Mycobacterium, Neisseria, 
Staphylococcus, Streptococcus, and Ureaplasma. Species and 
strains are shown in Table S1 in Supplementary material. 
Proteomes ranged in size from approximately 6000 proteins 
(Burkholderia) to 689 (Ureaplasma). In total 427,906 proteins 
were included in the final pathogen dataset, comprising 
1.16 × 108 total TCEM in each of the three TCEM contact 
patterns.
d. Immunoglobulin variable regions (IgV): the 40,000 heavy 
chain V regions were assembled as previously described 
(1). A further 16,000 light chain variable regions were 
also retrieved from Genbank and curated to remove those 
derived from immunopathologies, using the same criteria as 
described for the heavy chains. The final reference databases 
1 www.uniprot.org
2 www.hmpdacc.org/HMRGD
3 www.patricbrc.org
comprised approximately 6.4 ×  106 total TCEM, including 
325,000 unique motifs in each of the three contact patterns.
analysis of T-cell exposed Motifs
To construct the TCEM sets, concatenated amino acid FASTA 
files of each of the proteomes were assembled, from which each 
protein in the proteome was then decomposed into sets of 9-mer 
and 15-mer peptides, each offset by a single amino acid and 
placed in successive rows of a JMP® data table. Three different 
TCEM contact patterns were constructed from each peptide 
in corresponding columns using column formulas of JMP®. 
These were TCEM I comprising amino acids (4,5,6,7,8) of a core 
MHC-I 9-mer, and TCEM IIa and TCEM IIb comprising amino 
acids corresponding to amino acids (2,3,5,7,8) and (-1,3,5,7,8) 
of the central 9-mer core of a 15-mer (1, 2). Hence, each 9-mer 
yielded a motif in the format ~~~~XXXXX~ where ~ represents 
a non-exposed amino acid, and each 15-mer yielded a motif in 
the format ~~~~XX~X~XX~~~~ or ~~X~~X~X~XX~~~~. 
The GEM responsible for the binding interactions was similarly 
assembled as the intercalated set of non-exposed amino acids in 
each peptide. The unique identifier of each protein, the peptide, 
and the N terminal positions of each peptide in the parent protein 
within the proteome were retained with each TCEM. In this way 
TCEM sets were hyperlinked to the parental proteins by JMP® 
so that the parental proteins could be readily retrieved for other 
analyses. Three sets of tables, one for each TCEM contact pattern, 
were constructed for each protein set.
Frequency and Diversity analysis of 
Proteome TceM
Preliminary analysis of TCEM frequencies in the different pro-
teomes indicated that they all exhibited a log-normal distribution 
pattern characterized by two parameters: a mean (μ) and a scale 
factor (σ) analogous to an SD. In keeping with our previous use 
of a log2 base for characterizing the frequency-of-occurrence 
of TCEM in IgV (1), each motif was characterized according to 
the frequency of occurrence in each particular proteome. The 
diversity of TCEM occurrence in each proteome was computed 
as the Shannon Entropy H as
 
H = −∑p 
N
log2 p
1  
where p =  frequency of occurrence of a particular TCEM and 
N =  total number of TCEM in the proteome for the contact 
pattern.
TreeMapping of Multivariate Datasets
Treemaps were used to visualize underlying patterns in large 
multivariate datasets and were particularly useful for displaying 
hierarchical data as a set of nested rectangles. Briefly, TCEM usage 
in each proteome was tallied for each of the proteomes. Each of 
the proteomes exhibited a pattern of motif use, some of which 
was shared with other organisms and the human proteome, and 
some of which was unique to the particular organism. An N × M 
TaBle 1 | composition of TceM iia proteome datasets.
TceM count human Pathogen Microbiome Percent of  
3.2 million
2,090,606 1 1 1 65.3
216,262 1 0 1 6.9
413,177 0 1 1 12.9
201,400 0 0 1 6.3
46,575 1 1 0 1.5
59,256 1 0 0 1.9
51,041 0 1 0 1.6
121,683 0 0 0 3.8
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matrix where N = 3.2 million and M = the number of proteins 
was created which contained the tallies of the number of each 
of the particular TCEM. Then a binary string was created which 
described the presence or absence of each of the motifs across 
all proteomes. This string pattern was used to create a treemap 
of comparative TCEM content across proteomes. This process 
works well for a number of proteomes within a genus, and across 
genera and provides a useful way to compare and visualize large 
proteomic datasets.
immunoglobulin TceM Frequencies
The TCEM in each of the proteomes described were character-
ized as to whether or not they were present in immunoglobulins 
and, if present, their particular frequency of occurrence in 
immunoglobulins. It should be noted that in this paper we use 
the frequency of TCEM occurrence based on total TCEM within 
the whole immunoglobulin dataset. This differs from our prior 
analysis where only IgV data was analyzed (1), and hence where 
frequencies were standardized to the number of IgV clonotypes.
software
All data processing, pattern analysis and statistical analysis were 
done with JMP® v12 from SAS Institute (Cary, NC, USA).
resUlTs
All data described in the Section “Results” are for TCEM IIa, 
corresponding to MHC II mediated CD4+ responses. The cor-
responding results of analysis for TCEM I, for MHC I CD8+ 
responses, is appended in the Supplemental Tables and Figures. 
Results for TCEM IIb are not shown but are very closely analogous 
to TCEM IIa, as are results observed for all three contact patterns.
TceM content and Frequency Distribution 
in human Proteome, Microbiome, and 
Pathogen Datasets
Based on the pentamer contact pattern, there is a maximum of 
205 possible TCEMs (3.2 million) for each of the three contact 
patterns TCEM I, IIa and IIb. Table 1 shows the frequency dis-
tribution of TCEM IIa in each proteomic dataset. None of the 
proteome datasets uses the full complement of possible TCEMs 
and there is a varying degree of overlap between proteome data-
sets. The Human proteome dataset comprises 2,412,699 unique 
TCEM, or only about three quarters of the maximum possible 
motifs (Table 2; Figure 2). Of these, 2,090,606 are shared with 
both the Microbiome and Pathogen composite proteome sets. The 
Human proteome shares a further 216,262 motifs with only the 
Microbiome. A smaller set of 46,575 additional TCEMs is shared 
by only the Human proteome and the Pathogens. The Pathogen 
set and the Microbiome sets share 413,177 motifs that are missing 
from the Human proteome, however this reflects a more com-
plex underlying species-specific relationship (Tables  S6 and S7 
in Supplementary material). Only 59,256 motifs are completely 
unique to the Human proteome and not found in the bacterial 
sets. A final 121,683 possible motifs are not used by any of the 
proteome sets, as discussed further below.
The frequency distribution of motif usage within each of the 
three proteome sets is log-normal (KSL goodness of fit p < 0.001 
(15). As is shown in Figure 3A both the mean (μ) frequency and 
the variation (σ) in occurrence are similar between the three dif-
ferent proteomic data sets. The log2 mean of the distributions is 
about μ = −20 (μ = −20.3 for human proteome) for each of the 
proteomes (1/220 = 1/1,048,576) or a somewhat greater frequency 
than 1/3,200,000 that would be expected for a totally random dis-
tribution. Moreover, a very slight skewing of the histograms can 
be seen relative to the overlayed normal distribution curve. The 
crosshatched insets are the IgV TCEM frequency distribution, 
which also show a log-normal distribution. The size of the IgV 
database used in this analysis is approximately 1% of the total clo-
notypes that might be found in a single human (12), but even this 
relatively small sample of total clonotypes provides a considerable 
intersection with the proteomic data (Table  2). Additionally, 
allowing for a single conservative amino acid replacement (16, 
17) at any of the five amino acid positions in the TCEM pentamer 
expands coverage by the IgV-derived motifs to about half of the 
total motifs in the proteomes (Figure  3B). Comparison of the 
distribution means in Figures 3A,C shows that in each case the 
mean of the IgV distribution is slightly shifted toward a higher 
TCEM frequency as compared to the mean of the proteome as a 
whole (μ difference 0.4–0.5 log2).
Motif Usage in immunoglobulin  
Variable regions
The log-normal pattern of TCEM recurrence frequency seen in 
the three proteome data sets, described above, is very different 
from the frequency of occurrence pattern of motifs found in the 
IgV, and as previously reported (1). The IgV dataset comprises 
only 322,058 unique motifs in the TCEM IIa contact pattern but 
these have a distinctive frequency distribution pattern of motif 
re-use. The overall frequency of germline-origin and somatic 
hypermutation-origin sequences is seen in Figure 4.
The different underlying basis of the diversity in the IgV, the 
Human proteome and the two bacterial proteomes is evident 
in the Shannon entropy of the TCEM motifs in the different 
datasets (Table 3). Since the frequency of occurrence of TCEM 
is the base of the metric, the entropy calculation is standard-
ized for dataset size, so the values derive from the differences 
between the combinatorial frequency patterns of the IgV and the 
proteomes. The difference in patterns as well as the differences 
FigUre 2 | Occurrence of the 3.2 million possible motifs. The chart 
shows the distribution of the maximum possible TCEM IIa pentamer motifs 
among the three proteome datasets.
TaBle 2 | Fractional composition of proteomic datasets and fractional matches of igV TceM iia motifs.
group count Percent of 3.2 million igV coverage igV motifs Percent of total igV motifs
Human 2,412,699 75.4 11.6 279,108 85.9
Human excludedb 787,301 24.6 5.5 42,950 13.3
Pathogen 2,601,399 81.3 11.5 298,764 92.8
Pathogen excludedb 598,601 18.7 3.9 23,294 7.2
Microbiome 2,921,445 91.3 10.7 313,197 96.4
Microbiome excludedb 278,555 8.7 3.2 8,861 2.7
Not found in human, pathogen or microbiomea 121,683 3.8 2.4 2,900 0.9
aThis set is included in the three excluded sets marked “b”. 
bExcluded sets.
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in entropy can be understood by the fact that the IgV begins as 
the same germline set (albeit from a number of different gene 
families) which becomes increasingly diverse during the course 
of somatic hypermutation and thus comprises highly diverse 
sequences but which are systematically created from a constant 
starting point.
Given the differences in overlap between proteome sets, we 
were interested to examine what the degree of overlap with TCEM 
used in IgV was for each proteome. At a full dataset scale there 
was a slight bias in the IgV matches toward the more commonly 
encountered motifs (Figure 3A). We compared the frequency of 
usage of TCEMs in each of the three proteome data sets to that in 
the IgV dataset by subsetting the proteomes into the discreet IgV 
log2 based frequency categories (FC) as previously described (1). 
In this system TCEM motifs are characterized by the number of 
B-cell clonotypes that display the particular motif; hence a motif 
designated as FC3 occurs in 1 in 8 B-cell clonotypes and a motif 
of FC10 occurs in 1 in 1024.
We found that every FC subset of IgV TCEM matched 
a random sub-sample of each of the three of the proteomic 
datasets (Figure S3 in Supplementary Material). There is a slight 
tendency toward the high frequency FC motifs from IgV having 
greater overlap with the higher frequency motifs in the Human 
proteome (μ = −18.2 for FC7 vs. μ = −19.7 for FC12). Overall, 
however, there is a substantial overlap with the full gamut of 
different frequency peptides in the three proteome sets. The IgV 
frequencies thus effectively comprise a stratified random sample 
of TCEMs that the immune system will encounter. Motifs from 
the three proteomes are randomly distributed within each of the 
IgV FC categories.
That there is a slight bias in the coverage of IgV can be seen in 
a different way in Table 2; the IgV TCEM database has a total of 
279,108 matches of the 2,412,699 motifs in the Human proteome, 
an 11.6% match. This match is with 85% of the IgV database, 
which in total approximates only 1% of total B-cell clonotypes 
that an individual might carry. This suggests that with a complete 
B-cell repertoire, there might actually be a redundant level of 
motif matching across all Human Proteome motifs. The bias of 
IgV matches toward the more commonly used motifs is likewise 
seen in the Pathogens (11.5%) and in the Microbiome (10.7%). 
Thus in each proteome, while the IgV match seems to favor the 
more commonly encountered motifs, which are present more 
often than 1 in 1024 IgV clonotypes, the somatic hypermuta-
tion process is evidently capable of generating a range of motifs 
beyond what are found in the TCEM of the Human and bacterial 
proteomes.
We hypothesized that commonly used pentamers might serve 
some consistent structural or functional role in proteins. If so, 
then the relative frequency of occurrence of particular pentamer 
motifs would be the same regardless of the source organism 
as motifs that serve critical physicochemical roles in protein 
structure would be expected to occur in either bacteria or man 
at similar frequencies. To evaluate this we computed the overall 
rank correlation of usage frequency in the different proteomes 
(Table 4). The Spearman rank correlation in motif usage between 
Microbiome and Pathogen proteomes is 0.7. Although quite high, 
it is clearly substantially less than unity. The rank correlation was 
lower still between either of the bacterial sets and the Human pro-
teome at approximately 0.5 indicating that human and bacteria 
comprise different patterns of TCEM in building proteins. The 
rank correlation between IgHV and IgLV motif usages is 0.27 but 
the correlations of usage between the IgV and all of the proteomes 
is very low (0.03–0.06), indicating no structural or functional 
relationship of IgV to the proteome sets.
Missing Motifs
There are 121,683 motifs of the 3.2 million possible that are absent 
from all three proteome datasets (Table 1; Figure 2). The amino 
acid composition of this set of “forbidden” motifs comprises high 
TaBle 3 | shannon entropy of TceM iia motifs in different proteome 
subsets.
source shannon entropy (H)
Human and pathogen 20.3
Human and microbiome 20.6
Human 20.4
IgVL 12.3
IgVH 12.5
FigUre 3 | histograms of TceM iia in each proteome set 
analyzed. (a) The frequency of occurrence of each of the possible 
205 TCEM IIa pentamers was computed for all of the proteins in  
each of the proteomes. The fit of a frequency-weighted normal  
distribution to each of the datasets is shown by the solid curve. The  
number of motifs and the parameters of the normal distribution curve  
are given in the inset. The cross hatched region within the histogram 
corresponds to the frequency of IgV-origin TCEM IIa. X axis shows the  
log2 of frequency of occurrence. (B) The background frequency distribution 
is as in (a) but showing the overlap of IgV TCEM IIa pentamers when a 
single conservative amino acid replacement is permitted. (c) Separation  
of the IgV origin pentamers for the Pathogen proteomes to show  
germline-origin and somatic hypermutated-origin subset distributions of  
the IgV TCEM IIa.
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percentages of tryptophan, methionine, cysteine, and histidine 
(Figure  5A). The overall coverage of these missing motifs by 
motifs found in the IgV dataset is 2.4% or 2900/121,683 and 
TCEM of all IgV FC are represented. Again, a complete B-cell 
repertoire would likely provide more complete coverage of even 
these rare motifs. Hence, the mutational process generating the 
IgV can create even this “forbidden” subset of TCEM that are not 
found in the Human proteome or in the very diverse bacterial 
proteome datasets.
TceM Frequency Patterns within the 
Bacterial Datasets
Although at a global level the individual bacterial proteomes 
making up the bacterial datasets are quite similar in TCEM 
occurrence frequency, there are clear differences in detail of 
the constituent bacterial proteomes that may be of immuno-
logical significance. We observed two independent types of 
patterns of TCEM occurrence in individual proteins in the 
bacterial sets:
 (a) some genera comprise many proteins with a high percentage 
of IgV motif overlap, and
 (b) each bacterial genus and some species exhibit a character-
istic signature of motif usage and of motif overlap with the 
Human proteome.
FigUre 4 | Frequency distributions of igV-origin TceM iia motifs for 
the Pathogen proteome. Shows the frequency distribution of the IgV TCEM 
IIa motifs in the Pathogen proteome set as shown by the cross hatched 
insets in Figure 3a. The bars in the histogram represent the fraction of the 
total motifs at the particular frequency. The crosshatched region depicts the 
fraction of the total at the particular frequency that is of germline-origin and 
the solid portion of the bar is attributable to somatic hypermutation origin 
motifs. X axis shows the log2 of frequency of occurrence.
FigUre 5 | amino acid frequencies in the TceM iia pentamers. 
(a) Amino acid frequency in the potential motifs which are not found in any of 
the proteomes evaluated. (B) Amino acid frequencies in the motifs used by all 
bacteria in both Pathogen and Microbiome sets and the Human proteome.
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Comparison of IgV TCEM Content in Pathogen  
and Microbiome Proteomes
As shown in Figure  6, when the proteomes of each bacterial 
Pathogen genus analyzed are arrayed by their IgV motif content, 
there are clear differences between genera and between species 
and the IgV motif found in the Human proteome (see also Table S6 
in Supplementary Material for analysis of variance). In particular, 
Burkholderia spp and Mycobacterium spp exhibit a large number 
of proteins with up to 50% IgV motif content. As a group, the 
TaBle 4 | rank correlation of TceM iia occurrence between different 
proteomic subsets.
Variable By variable spearman ρ Prob > |ρ|
log2 Human freq log2 Microbiome freq 0.5249 <0.0001
log2 Pathogen freq log2 Microbiome freq 0.7404 <0.0001
log2 Pathogen freq log2 Human freq 0.5060 <0.0001
log2 IgVL freq log2 Microbiome freq 0.0621 <0.0001
log2 IgVL freq log2 Human freq 0.0652 <0.0001
log2 IgVL freq log2 Pathogen freq 0.0512 <0.0001
log2 IgVH freq log2 Microbiome freq 0.0496 <0.0001
log2 IgVH freq log2 Human freq 0.0382 <0.0001
log2 IgVH freq log2 Pathogen freq 0.0372 <0.0001
log2 IgVH freq log2 IGVL freq 0.2699 <0.0001
majority of the selected Pathogens have a higher content of TCEM 
shared with IgV than does the Human proteome. In Burkholderia 
spp and Mycobacterium spp in particular there are entire families 
of proteins that have high IgV similarity. The high IgV TCEM 
content is found in individual proteins and in classes of proteins 
sharing functional similarities. Proteins of some Pathogen genera 
have a lower overall IgV motif content, but each has a small num-
ber of proteins that are outliers with respect to their IgV motif 
content. As Figure 6 also indicates (see coloration) these outliers 
with higher IgV match include quite large proteins (>2000 amino 
acids) and IgV content is expressed as a percentage of TCEM, so 
their size might be expected to significantly contribute to their 
overall immunological effect.
In contrast, applying a similar analysis to the Microbiome set 
(Figure 7; Table S7 in Supplementary Material) does not reveal 
differential distribution with respect to IgV motif content. All of 
the genera have similar patterns, although notably Escherichia, 
included in the Microbiome set, does have a slightly higher 
content of IgV motifs. In part the lack of distinct patterns among 
the Microbiome maybe attributable to the taxonomic diversity, 
however the IgV motif content is overall similar to the lower 
range seen in the Pathogen set.
To relate the IgV content to Human proteome content we 
applied the frequency-weighted distributions for TCEM as 
shown in Figure 2A. Each TCEM in the proteins of the proteomes 
of Figure 6 was assigned its standardized frequency (σ position 
on the normal distribution curve in the Human proteome shown 
in Figure  3A). Then, this TCEM metric was averaged across 
each protein to give each protein an overall score, essentially a 
“human-like” score for an entire protein. As an example Figure S8 
in Supplemental Material shows how the IgV and human score 
compare for B. pseudomallei. The patterns demonstrate that the 
high frequency IgV-origin TCEM also indicates an unusually 
high content of Human proteome motifs.
Organism-Specific Motif Signatures
We next addressed the genus-specific occurrence of TCEM 
within the proteome datasets by using treemapping to examine 
the intraset differences in presence and absence of motifs. The 
treemaps each depict the underlying patterns of occurrence 
over 108 TCEM. The graphics each contains between 1.5 and 2.5 
million rectangles. Each rectangle represents a unique TCEM 
sharing relationship of motifs among bacterial species and is sized 
to represent the number of motifs within that combination. The 
treemap for the Pathogen data set is shown in Figure 8. Figure S12 
in Supplementary Material shows magnification of a small area of 
the upper left corner of Figure 8 to show the underlying detail 
of motif sharing relationships. Strikingly, within the very large 
Pathogen dataset there are a number of relatively large rectangles 
visible in Figure 8. Each of the large rectangles contains a motif 
combination, or signature, that is unique to one or more species 
of a single genus. For instance, Streptococcus pneumoniae (Box 
19) has 6,568 TCEM IIa pentamers not found in the other 131 
species analyzed. The top 20 in each of the Pathogen proteomes 
is indicated in the table accompanying Figure 8. Each of these 20 
rectangles each represents 0.84–4.05% of the total proteome of an 
organism. Thus, each organism contains a subset of TCEM that 
FigUre 6 | igV TceM iia frequency patterns within the Pathogen proteomes. X axis: groups of five Pathogen total proteomes are clustered by genus with 
each protein represented by a colored dot. Y axis shows the percentage match of IgV TCEM IIa in each protein. Each dot represents the metric computed for a 
single protein in the proteome of the different organisms. The color of the dot is proportional to the molecular weight of the protein. For example, Mycobacterium 
tuberculosis has a number of relatively large proteins which have nearly a 50% match to the IgV motifs. The inset box shows the interquartile range of the metric in 
each of the proteomes and the whiskers indicate the 10 and 90% of the metric. For the human proteome the average content of IgV TCEM IIa is 17.3%.
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are unique to itself and that in some cases comprises a significant 
fraction of its entire proteome. There are also sets of motifs that 
are universally shared or nearly so, shown in dark red boxes in 
the upper left corner of the treemap. These are the motifs that are 
found in every bacterial species in the set.
When the Pathogen set was then combined with the Human 
proteome it emerges that that nearly every bacterial species has a 
subset of its genus-specific TCEM that it shares with the Human 
proteome (Figure  9). This overlap is to be expected based on 
the general overlaps shown in Table 1. In Figure 9, the TCEMs 
unique to the Human proteome and not found in any of the 
132 proteomes of the Pathogen set are represented in the largest 
rectangle. The other large rectangles identify motifs shared by 
Human proteome and one or more Pathogens as indicated in the 
Table in Figure  9. For example, Coxiella burnetti (Box 12) has 
7,792 motifs uniquely shared with the Human. A human would 
obviously not encounter all of the Pathogens simultaneously and 
the patterns seen when the Human proteome is compared to any 
one of the Pathogens is itself quite striking. Figure 5B shows the 
amino acid composition of the 615 motifs shared among Human 
and both bacterial proteome sets. These motifs favor leucine, 
glycine, alanine, and isoleucine.
Figure 10 shows the corresponding patterns of unique bacterial 
signatures for the Microbiome bacteria analyzed. Here the unique 
signatures tend to constitute a smaller fraction of the individual 
proteomes, from 0.66 to 1.7%, however this may be a reflection of 
the greater diversity of genera in this dataset. Figure 11 shows the 
unique patterns of sharing with the Human proteome of TCEM 
in the Microbiome.
To illustrate how identical TCEM may be associated with 
multiple different GEMs and thus have different MHC binding 
affinities in their source protein, a small subset of TCEM shared 
between Human proteome and Burkholderia pseudomallei (Box 8 
of Figure 9) were examined. An example of this comparison is 
provided in Figure  12. Here it is seen that a single TCEM IIa 
~~~~HV~R~SR~~~~ was found in 10 different human proteins 
and 3 different B. pseudomallei proteins. The 15-mer context is 
different in each case and this means the predicted MHC binding 
for each is different. While DRB1*01:01 binds relatively poorly 
to all the 15-mers, DRB1*03:01 binds more strongly and in par-
ticular when the TCEM is in the context of one human protein 
15-mer (YWEVHVGRRSRWFLG) and the three B. pseudomallei 
proteins. While for each allele, the same T-cell would recognize 
the same TCEM, the cumulative duration and repetition of 
FigUre 7 | igV TceM iia frequency patterns in the Microbiome proteomes. X axis: groups of Microbiome proteomes are clustered by genus with each 
protein represented by a colored dot. Y axis shows the percentage match of IgV TCEM IIa in each protein. Each dot represents the metric computed for a single 
protein in the proteome of the different organisms. The color of the dot is proportional to the molecular weight of the protein. The inset box shows the interquartile 
range of the metric in each of the proteomes and the whiskers indicate the 10 and 90% of the metric. For the human proteome the average content of IgV TCEM 
is 17.3%.
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interaction would depend on the effect of the binding affinity 
on the peptide dwell time in the pMHC complex, and thus the 
probability of a productive T-cell encounter occurring.
As shown in Figure  3, TCEM frequencies are log-normally 
distributed and appear to be the result of random processes. Thus, 
unique motifs might occur at random anywhere in a proteome. 
However, on closer inspection a substantial number Pathogen-
unique “signature motifs” appear to cluster in individual pro-
teins, and even in relatively contiguous segments of proteins. A 
majority of the unique motifs represented in the larger boxes in 
the treemaps (Figure 8) are found in segments of only 50–100 
different proteins in each proteome.
DiscUssiOn
In the present study, we compare two diverse sets of composite 
bacterial proteomes, which coexist with the human proteome, by 
using the recognition patterns of the cellular immune system. We 
also compare the occurrence of the same recognition patterns in 
IgV and the human proteome. Genomic comparisons generally 
focus on analysis of single nucleotide or amino acid changes. 
By opting to use the TCEMs as the comparator, we are in effect 
looking how the proteins in the organisms are recognized by the 
T-cells as the initiator of any selective pressure by the cellular 
immune system.
A central challenge in immunology is to understand how self 
is distinguished from non-self. What emerges from our analysis is 
that, at least for the T-cell response, this concept is a considerable 
oversimplification of a complex signaling system. Indeed, what 
we observe in the present analysis is that what may be uniquely 
human is, at best, only a very small subset of the possible T-cell 
recognition signals. When viewed as TCEM pentamers recog-
nized by T-cells in contact pattern IIa and comparing the human 
proteome to a range of pathogenic and commensal bacteria, 
only 1.9% of the possible pentamers are unique to humans. If we 
consider all three contact pattern of T-cell recognition (TCEM I, 
IIa and IIb) then the truly unique peptides may be the multiple 
of these metrics and much smaller. The Microbiome dataset 
analyzed here is only a small subset of the total gastrointestinal 
microbiome. An individual human would not be exposed to all 
of the Pathogens simultaneously. However, over time, the larger 
the number of bacteria that are encountered, the more closely 
the number of TCEM unique to humans approaches zero. The 
organism-specific patterns would be expected to play a role in the 
overall recognition. Although no single TCEM that an individual 
T-cell receptor binds apparently defines self, the T-cell repertoire 
FigUre 8 | Treemap of TceM iia frequency patterns in the Pathogen proteomes. Each organism shows a different pattern of occurrence of the possible 205 
total motifs. This is a binary absence/presence depiction analogous to a Venn diagram. It comprises 1,540,176 different patterns of 110 million motifs. To construct 
this map tallies were made of each of the TCEM IIa motifs found in each organism’s proteome. A binary coding scheme was used to score the presence or absence 
of a particular motif (of 205 total) in a proteome. The size of the rectangle is proportional to the number of motifs. The lightly colored rectangles indicate relatively rare 
motifs and the dark rectangles indicate common motifs. The large rectangles indicate motifs unique to one or a few species; the organism corresponding to each 
large rectangle is shown in the accompanying tabulation along with the number of motifs in each of the N proteome and the fraction of the total of each proteome of 
the organism represented by those motifs. Not visible at this resolution in the upper left hand, darkly colored area, there is a rectangle comprising 615 “universal” 
motifs that are found in every proteome in this set.
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as a whole is capable of uniquely recognizing the overall compos-
ite patterns.
The TCEM does not function alone in determining the 
outcome of a T-cell–peptide interaction, but is recognized 
within the context of the surrounding MHC histotope. An 
individual host has a limited set of MHC alleles, which can 
present a peptide and thus form the surrounding histotope 
surface. Furthermore, the binding affinity of the inner face of 
the MHC-bound peptide, the GEM, determines the dwell time 
of the peptide in the MHC groove and hence the probability of 
productive T-cell:pMHC encounter, the duration of any T-cell 
interaction, or how many times it is repeated. Here again an 
individual’s HLA alleles are determinants of the T-cell response. 
Thus, both “faces” of the peptide, T-cell exposed and groove 
exposed, modulate the overall outcome in the context of the 
host’s immunogenetics (19, 20). One example of this is provided 
in Figure 12.
The diversity in possible GEMs is also vast. In the case of 
MHC I, the GEMs comprise 204 potential combinations (assum-
ing a 9-mer peptide), and for MHC II a further 2010 (assuming 
a 15-mer) combinations exist. These 2010 variants in GEM are 
multiplied by the potential 3.2 million different TCEMs to arrive 
at the maximum number of potential specific interactions of 
peptides with T-cells in each of the three contact patterns. GEMs 
determine on-off rate, or duration, of peptide MHC binding. 
However, it is the TCEM, and the frequency of its occurrence, 
which determines the size of the cognate T-cell population 
responding to the peptide and which can hence contribute to 
FigUre 9 | Treemap of combined TceM iia frequency patterns in the Pathogen proteomes and the human proteome. The algorithm is the same as 
used in Figure 7 but in this case the human proteome was also included in the analysis. This shows the inter-relationship between the motifs of the Pathogen and 
the Human. It comprises 1,585,188 different motif sharing patterns. The accompanying tabulation of the 20 largest boxes indicates the composition depicted in 
these rectangles. For example, Box 1 shows that there are 275,510 motifs are unique to humans and not found in any of the pathogens whereas Box 2 shows the 
number of motifs that are found in both the C difficile and Human proteomes and indicates that 14,189 of the 22,843 unique Pathogen motifs found in the organism 
(Figure 7) are also found in the Human proteome. Overall, this shows a remarkable overlap between the T-cell motifs found in the proteins of pathogens and those 
found in humans.
October 2015 | Volume 6 | Article 53811
Bremel and Homan T-cell epitope repertoire sharing
Frontiers in Immunology | www.frontiersin.org
T-cell repertoire phenotypes and the balance of immune stimula-
tion or suppression (21, 22).
Common TCEM, like those found repeatedly in IgV, provide 
for a higher frequency of interaction with cognate T-cells. 
Higher signal strength generated through a combination high 
frequency pMHC:T-cell contact and longer interaction dwell 
time favors emergence of a Treg phenotype, through a combi-
nation of Foxp3 induction (23) and epigenetic changes in the 
T-cells (24–26). Higher affinity MHC binding of the peptide 
GEM ensures a longer dwell time and thus more opportunity 
for interactions at the T-cell exposed face. Implicitly, high 
frequency TCEMs may build up a larger cognate T-cell popula-
tion. So provided they also occur in peptides which bind well 
to the MHC, high frequency TCEMs will therefore be expected 
to generate more Tregs. The balance of Treg and T-effectors 
is modulated by IL2 secretion by T-effectors and binding and 
removal of IL2 by Treg (27–29). Local binding of IL2 will accel-
erate Treg proliferation, suppressing effector responses in the 
vicinity and potentially leading to greater numbers of residual 
cells of the same specificity available for future interaction (30). 
Such a feedback loop driven by the frequency of TCEM appear-
ance is consistent with a form of quorum sensing among T-cells 
(31). It also indicates that down-regulation and homeostasis is 
likely the norm driven by common TCEM. Conversely, the 
lower frequency motifs are likely to be more important in 
discriminating between self and non-self and in generating an 
upregulated immune response.
A further consideration is the abundance of the protein in 
which a TCEM is located, how frequently it is transcribed and 
catabolized, and its accessibility to antigen presenting cells. In 
the case of bacterial proteomes, these factors will change either 
as different proteins are expressed with the stage of infection 
or with changes in the microbial ecology of the microbi-
ome. Interestingly, this may make the modulating role of 
immunoglobulin-derived peptides relatively more important as 
immunoglobulins are constantly accessible, readily processed, 
and presented by B cells.
While we have interpreted the exposure of amino acids in 
TCEMs in three simple contact patterns based on the struc-
tural analysis of Rudolph et al. (2), flexibility of peptides may 
accommodate some bulging and twisting of MHC-bound 
peptides to create some variability in the TCEM exposure 
(32) and so we expect that the interaction will be much more 
nuanced. Additionally other studies have examined the relative 
importance of each amino acid in the binding groove (33). A 
further compounding factor is that there may be multiple clonal 
FigUre 10 | Treemap of TceM iia frequency patterns in the Microbiome proteomes. See Figure 7 for more complete description. This treemap comprises 
2,092,911 different motif sharing patterns.
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lines of cognate T-cells for any unique TCEM; there is not a 
one-to-one correspondence of TCEM and T-cell receptor and 
a T-cell receptor may bind with more than one TCEM-MHC 
combination, through recognition of physicochemical near 
neighbors (16, 17).
comparative Overlaps in Motifs among 
Proteomes analyzed
The bacteria selected for inclusion in the Pathogen set comprised 
human pathogens, which are generally directly transmitted, not 
vector borne. With exception of the Clostridium spp, we excluded 
genera that are typically fecal-oral transmission. This was 
intended to maintain a clear distinction from the array of bacteria 
included in the gastrointestinal Microbiome group. Similarly, we 
opted to include Escherichia spp in the Microbiome set. Such 
decisions about opportunist pathogens certainly affected the 
degree of overlap we observed, but do not detract from the overall 
conclusions. It is noteworthy that E. coli is an outlier among the 
Microbiome set in Figure 7 with respect to its IgV TCEM content. 
This is consistent with the prior observations that E. coli contains 
a number of immunoglobulin domains (34).
As bacteria are constantly evolving at different rates, and 
microbiome composition is affected by external factors, the 
isolates from which we analyzed sequences simply represent a 
cross sectional sample or “snapshot” of a dynamic process. Had 
different bacterial isolates been incorporated into the analysis, 
results would have differed in detail, but likely not the overall 
conclusions. Similarly, by selecting the gastrointestinal micro-
biome, we do not underestimate that the microbiota of other 
mucosal surfaces exercise a similar relationship with the human 
proteome and IgV and undoubtedly also influence immune 
modulation (35).
In the analysis conducted, we demonstrate that there are dif-
ferent and distinctive patterns of TCEM occurrence in the three 
proteome groups. Interestingly, the Human proteome utilizes 
only about three quarters of the possible pentamers and has 
a relatively small set of 59,256 unique motifs not found in the 
Microbiome and Pathogen proteomes analyzed. Both bacterial 
proteome sets we examine overlap extensively with the Human 
proteome. Slightly more overlap occurs with the resident gastro-
intestinal Microbiome perhaps indicative of a longer homeostatic 
coexistence.
This high degree of TCEM commonality underscores the 
impossibility of central tolerance to all self-antigens (36, 37). 
Rather, it argues for functional modulation of peripheral 
T-cell responses to specific TCEM along a spectrum of Treg 
to T-effector, enabled by T-cell plasticity of phenotype (38, 
39), and the localization of responses in response to mucosal 
microbiome or to infection (40–42).
While there appears to be no overriding requirement for any 
given motif driven by basic protein structure, there is a fairly 
large set of almost 121,683 motifs, which are absent from all 
three proteome groups. These “forbidden” motifs have amino 
acid compositions in common that are high in cysteine, histidine, 
methionine and tryptophan (Figure 5A). The side chains of these 
FigUre 11 | intersection between the human proteome and the Microbiome. See Figure 9 for more complete description. This treemap comprises 
2,144,076 different motif sharing patterns.
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amino acids each have physicochemical properties that make it 
unlikely for them to be in close proximity to each other, which 
may bias against their use. Conversely, there is a group of motifs 
that are a relatively smaller “universal set” found in all organisms. 
Amino acid compositions of these TCEM showed a high content 
of the hydrophobic amino acids known to be commonly found in 
membrane-spanning helices.
Motif Patterns in immunoglobulins
We show that the diversity of peptides generated within immuno-
globulin variable regions is broadly representative of the TCEM 
in all three proteome datasets and our IgV dataset comprises a 
stratified random sample across the array of all possible TCEM. 
We see that our database of 56,000 IgV sequences provides a 
balanced random coverage for both the human proteome and 
the two bacterial proteome sets we used in our analysis, and 
even represents the “forbidden” motifs never used in the three 
proteome groups. Thus, the somatic mutational process that gen-
erates immunoglobulin variable regions is evidently capable of 
generating any possible 9-mer or 15-mer peptide. As the dataset 
of immunoglobulins analyzed is only about 1% of the full comple-
ment of IgV that any individual would carry (12), it appears that 
the diversity of TCEM within IgV may be able to stimulate and 
maintain a T-cell repertoire that is capable of responding to all 
potential T-cell immunogens. This supports the hypothesis that 
the frequency of motif occurrence in the IgV may modulate the 
T-cell repertoire in the face of selective pressure and assist in 
maintaining homeostasis and memory (1).
Immunoglobulins are unique compared to the rest of the 
human proteome in their immense diversity and in their turnover 
rate. A human carries about 3–9 × 106 unique B-cell clonotypes 
(12) yielding variable regions which, combining both light and 
heavy chains, each have approximately 260 unique sequential 
peptides. In aggregate, therefore, the immunoglobulin of an 
individual human comprises a billion or more unique peptides 
yielding TCEMs in each contact pattern. Moreover, the lifespan 
of a B-cell is estimated to be of 30–60 days (43) and each immu-
noglobulin about 14 days (44), so there is considerable turnover. 
At a serum concentration of about 11 g/l the diverse mass of IgV 
constitutes about 75 g in an adult human (45, 46). In contrast, 
the remainder of the human proteome comprises approximately 
20,000 proteins averaging about 384 amino acids apiece, or about 
7 million unique peptides and has a slower rate of turnover. Thus, 
immunoglobulins constitute a massive, dynamic protein pool 
with enormous peptide diversity available throughout the body.
The broad representation of motifs within the IgV with a 
range of frequency-of-occurrence of about 216 and which are 
being consistently presented to T-cells (6), also implies that at 
FigUre 12 | Differential predicted Mhc binding of peptides from human and bacterial proteomes with identical TceM but different groove exposed 
motifs. Examples shown are from Box 8 in Figure 9, which comprises 8,726 total motifs. (a) Binding affinities were computed for the MHC II alleles indicated using 
previously described methods (18) and standardized to zero mean and unit variance within the parent protein. The color scale shows predicted binding in SD units. 
Source proteins listed by Accession number are listed in full in Table S10 in Supplementary Material. (B) Peptides a and b shown in (a) are shown with the T-cells 
exposed amino acids and the groove exposed amino acids identified.
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any time the T-cell repertoire contains a gradation in frequency 
of cognate T-cells ready to respond to a fraction of the Pathogen 
or Microbiome motifs whenever these are first encountered. 
These may constitute a “starter set” of first responders, which can 
expand in size and which can be supplemented by respondents to 
the other motifs. This response would be supplemented by near 
neighbor matches, in which four of five amino acids generate a 
near fit (16, 17). The sharing of the same T-cell recognition motifs 
by the human proteome, IgV, and in the Pathogen sets accounts 
for the observations by others that naïve T-cells sampled from 
cord blood have the innate ability to recognize pathogens (47, 
48). While most observations on cord blood have focused on viral 
pathogens there is no reason to think they would be more diverse 
in TCEM usage than bacteria. It is also consistent with the role of 
the microbiota in maintaining immune homeostasis (35).
The frequency distribution of motif occurrence in each of the 
three proteome sets is very similar and is log-normal. In contrast, 
the IgV-mutated set shows a Pareto distribution strongly biased 
toward the more common motifs (Figure 4). Although any pep-
tide can be generated by the IgV mutational process, within the 
IgV data set we examined, half of all the possible TCEM motifs 
reappear at least once in every 1024 B-cell clonal products (1). 
This means there is a greater degree of proteome overlap by the 
high frequency IgV motifs and a lesser overlap by the rare ones. 
The implication is that more common IgV TCEMs will likely 
engender larger T-cell populations, more memory, and more 
Tregs.
Not only is the somatic mutation process capable of 
generating a highly diverse set of TCEM, the appearance of 
TCEM in the IgV constitutes a stratified random sample of 
the TCEM distribution in the Human proteome and the 
bacterial proteomes. This implies that the TCEM frequency 
distribution observed in IgV can likewise be used as a means 
of characterization of TCEM in proteins from outside of the 
human proteome.
Patterns Within the Pathogen set
Members of the Pathogen set show clear differences in IgV-like 
motif content in their constituent proteins (Figure 6). Perhaps 
the most striking feature of this pattern is that two genera, 
Burkholderia and Mycobacterium, both intracellular organisms 
that cause chronic diseases, stand out as having many proteins 
October 2015 | Volume 6 | Article 53815
Bremel and Homan T-cell epitope repertoire sharing
Frontiers in Immunology | www.frontiersin.org
that contain motifs used at a high frequency in the IgV. In some 
proteins the IgV matched TCEM content is over 50% of the total 
TCEM motifs. These two genera also have a high level of uniquely 
shared motifs with the Human proteome exclusive of IgV 
(Figures 8 and 9). Selective advantage may be provided by the 
camouflage of using very common and likely immunosuppressive 
motifs. This is consistent with findings reported for Mycobacteria 
(49, 50). Further, in some pathogens, including Mycobacteria, 
we noted a higher distribution of IgV motifs in proteins that are 
upregulated early in infection (data not shown), indicating that 
the spectrum of overlap and immune recognition may change 
through the infective cycle.
A second striking observation is that, even with the limitation 
of 3.2 million TCEM motifs, certain subsets of a few thousand 
motifs were unique to particular bacteria, sometimes down to 
the species level. This pattern is maintained when the motifs in 
common with the human proteome are identified. While this pat-
tern will undoubtedly become more diffuse as more organisms 
are added to the analysis set, it indicates that there are specific 
signatures that could serve as targets for interventions.
Both these genus- and species-specific patterns point to 
possible different mechanisms of immune evasion arising from 
evolutionary pressure. For instance, while Burkholderia and 
Mycobacterium share many motifs with IgV and Human pro-
teome and also have fairly large sets of species specific motifs, 
Francisella is conspicuously absent from the larger clusters 
of unique signatures seen in Figures  8 and 9 and has a lower 
overall IgV TCEM content (Figure 6). It is not obvious what the 
evolutionary forces are which give rise to such signature patterns, 
but their existence suggests an important further line of inquiry 
toward better understanding of immune evasion and pathogen-
esis and to provide critical information for vaccine design.
The boxes in Figures  9 and 11, showing the complexity of 
TCEM overlap between Pathogen or Microbiome organisms 
with the Human proteome, indicate the extent to which a T-cell 
responsive to a bacteria may also respond to a human protein. 
Further examination of this overlap may shed light on how infec-
tions or alterations in commensal balance can trigger the onset 
of autoimmune diseases.
The limitation of 3.2 million TCEMs in each frame accounts 
for the widely observed T-cell polyspecificity (51–53) and the 
overall physical limitations on T-cell repertoire size deduced by 
Mason (3). The motifs within the total possible array of 3.2 mil-
lion and, as we indicate here, a somewhat smaller actual utilized 
repertoire, have to enable recognition of all peptides of self and 
non-self origin. Unique recognition, and thus initial response as 
well as recall, depends on the combination of signals, not on a sin-
gle unique motif, and thus on the aggregate response of multiple 
T-cell clonal populations.
cOnclUsiOn
The analysis of proteomes based on the TCEM contact patterns 
provides insight into the immune recognition of different classes 
of organism. Overall, the approach we have used to analyze 
commonalities and differences provides a new perspective on 
the discrimination between self and non-self, underscoring that 
there is very little uniqueness to the individual TCEMs present 
in the human proteome. Thus, distinguishing self and not self is 
dependent on a pattern comprised of many TCEM and which 
includes the relative frequency of each. This analytical approach 
can be applied more broadly. Any protein, proteome, or collection 
of proteomes, or mutated neoantigens, can be characterized by 
their TCEM pentamer content and frequency. This can provide 
insights and new experimental approaches to autoimmunity, aller-
gies, and other immunopathologies. In the case of the Pathogen 
set, the TCEM analysis indicates clear differences in motif content 
between proteins of different genera and species and provides 
clues to both immune evasion and strategies for intervention, 
including vaccine design. The breadth and distinct frequency 
patterns of the immunoglobulin-derived peptides again suggests 
a role of immunoglobulins in maintaining a broadly responsive 
T-cell repertoire and memory.
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